Come up with a name for your new list and we'll add to it:
Dynavax Technologies Corporation raised a round of funding on , . Investors include
Red Abbey Venture Partners.
Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative TLR9 agonist-based products to treat and prevent infectious diseases, allergies, cancer, and chronic infla…